Form D Explorer
Aligos Therapeutics, Inc. · CIK 1799448

Report a data issueCitable research briefCompare issuerPrivate research collection

Aligos Therapeutics, Inc.

CIK 1799448 · Corporation · Inc. DELAWARE · South San Francisco, California · Biotechnology
Sign up to follow Sign in for contact lookup
Filings
1
Original notices
1
Amendments
0
Activity
Feb 28, 2025
through Feb 28, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot

Form D · Feb 28, 2025

Reported offering amount
$105,003,206
Reported exemptions
Rule 506(b)
Reported amount sold
$105,003,206

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Form D filings (1)